Patients, clinics, and employees
As of September 30, 2023, Fresenius Medical Care treated 341,793 patients in 4,014 dialysis clinics worldwide and had 123,106 employees (headcount) globally, compared to 130,295 employees as of September 30, 2022.
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases of which around 3.9 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,014 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 342,000 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
All of the above from this link: The lead graphic is from a Bing search on stock FMS.
The bottom line is that FMS is the 100-pound gorilla in the dialysis arena. As a side note, in the recent past, they won a huge contract with the VA to provide dialysis services to veterans. It may be comforting to those on dialysis, regardless of the type, that they appear to be here to stay. Further, Ms Helen Giza, born in 1968, is their CEO @ $3.45 million per year. This is a bit more than my dialysis nurse Cindy makes, even with overtime.
Leave a Reply